Skip to main content
. 2021 Nov 11;4(4):381–390. doi: 10.3138/canlivj-2021-0016

Table 5:

Outcomes in screened and referred C282Y homozygotes

Screened*, No. (%) (n = 135) Referred, No. (%) (n = 392) χ2 (p-value)
Death 22 (16.29) 86 (21.94) 1.96 (0.16)
Cirrhosis 19 (14.07) 59 (15.05) 0.07 (0.78)
Knee or hip joint replacement 24 (17.78) 65 (16.58) 0.34 (0.56)

* Screened refers to a C282Y homozygote discovered during a population screening study

† Referred is a C282Y homozygote referred to a specialty clinic by a primary care physician